Global Primary Cells Market Overview:
Primary cells are cells isolated from human or animal tissues. There are two type of primary cell such as human primary and animal primary cells. The global primary cell market will boost due to various usage in healthcare domain, mainly for cancer research. Primary cells show high physiological similarity to the tissues and organs they are extracted from. This offers vast help to researchers and scientists in understanding various complexities related to drug pathways, studying diseases and drug development. According to AMA, the Global Primary Cells market is expected to see growth rate of 6.81%
- Increasing Demand in Cancer Research
- Rising Pharmaceuticals Outsourcing
- Up Surging Demand of Monoclonal Antibodies
- Enlarging Biotechnology as well as Bio pharmaceutical Industries
- High Cost of Advance Primary Cell
- Fueling Issues Regarding Primary Cell Culture Contamination
- Lucrative Opportunities in Primary Cells in 3D Culture
Some of the key players profiled in the report are Thermo Fisher Scientific (United States), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (United States), PromoCell (Germany), ZenBio (United States), STEMCELL Technologies (Canada), AllCells (United States), American Type Culture Collection (United States) and Axol Biosciences (United Kingdom). Additionally, following companies can also be profiled that are part of our coverage like Sigma-Aldrich (United States) and Cureline (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Primary Cells market by 2025. Considering Market by Origin, the sub-segment i.e. Hematopoietic will boost the Primary Cells market. Considering Market by End User, the sub-segment i.e. Research Institute will boost the Primary Cells market.
Latest Market Insights:
On 25th October 2018, Thermo Fisher Scientific Inc. (the global leader in serving science) has acquired Advanced Bioprocessing business from BD, a leading player of medical technology. The deal was established for 477 million dollar in cash.
On 22nd May 2018, Lonza has announced that the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. and On 15th March 2018, Thermo Fisher Scientific (the global leader in serving science) has started The SyncD3 Webinar series, to observe the Offerings and Applications of Primary Cell Systems in New Educational Webinar.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Primary Cells market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Primary Cells market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Biologics, Distributors of Human and Animal Primary Cells, Research Laboratories, Cancer Research Organizations, Biopharmaceutical Firms, Healthcare Institutes, Medical Centers, Government and Other Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.